131 related articles for article (PubMed ID: 6274453)
1. The interaction of fibrinogen with human platelets in a plasma milieu.
Marguerie GA; Thomas-Maison N; Larrieu MJ; Plow EF
Blood; 1982 Jan; 59(1):91-5. PubMed ID: 6274453
[TBL] [Abstract][Full Text] [Related]
2. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
Plow EF; Marguerie GA
J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
[TBL] [Abstract][Full Text] [Related]
3. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
[TBL] [Abstract][Full Text] [Related]
4. Binding of fibrinogen molecules to pig platelets and their membranes.
Cierniewski CS; Kowalska MA; Krajewski T; Janiak A
Biochim Biophys Acta; 1982 Feb; 714(3):543-8. PubMed ID: 6277391
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
Frojmovic MM; Mooney RF; Wong T
Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
[TBL] [Abstract][Full Text] [Related]
6. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
[TBL] [Abstract][Full Text] [Related]
7. ADP-dependent common receptor mechanism for binding of von Willebrand factor and fibrinogen to human platelets.
Timmons S; Kloczewiak M; Hawiger J
Proc Natl Acad Sci U S A; 1984 Aug; 81(15):4935-9. PubMed ID: 6087354
[TBL] [Abstract][Full Text] [Related]
8. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
Peerschke EI
J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of platelet function with synthetic peptides designed to be high-affinity antagonists of fibrinogen binding to platelets.
Ruggeri ZM; Houghten RA; Russell SR; Zimmerman TS
Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5708-12. PubMed ID: 3016716
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
Legrand C; Dubernard V; Caen J
Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
[TBL] [Abstract][Full Text] [Related]
11. Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair.
Di Minno G; Capitanio AM; Thiagarajan P; Martinez J; Murphy S
Blood; 1983 Jun; 61(6):1054-9. PubMed ID: 6301579
[TBL] [Abstract][Full Text] [Related]
12. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
13. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
14. Trigramin. A low molecular weight peptide inhibiting fibrinogen interaction with platelet receptors expressed on glycoprotein IIb-IIIa complex.
Huang TF; Holt JC; Lukasiewicz H; Niewiarowski S
J Biol Chem; 1987 Nov; 262(33):16157-63. PubMed ID: 3680247
[TBL] [Abstract][Full Text] [Related]
15. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of collagen-induced fibrinogen binding to human platelets.
Legrand C; Dubernard V; Nurden AT
Biochim Biophys Acta; 1985 Feb; 812(3):802-10. PubMed ID: 3970909
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of fibrinogen binding to stimulated human platelets by a monoclonal antibody.
Bennett JS; Hoxie JA; Leitman SF; Vilaire G; Cines DB
Proc Natl Acad Sci U S A; 1983 May; 80(9):2417-21. PubMed ID: 6302680
[TBL] [Abstract][Full Text] [Related]
19. Correlation between fibrinogen binding to human platelets and platelet aggregability.
Peerschke EI; Zucker MB; Grant RA; Egan JJ; Johnson MM
Blood; 1980 May; 55(5):841-7. PubMed ID: 6767512
[TBL] [Abstract][Full Text] [Related]
20. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets.
Gartner TK; Bennett JS
J Biol Chem; 1985 Oct; 260(22):11891-4. PubMed ID: 2995350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
